Pedro Shiozawa1, Mailu Enokibara da Silva1, Thais Cristina de Carvalho1, Quirino Cordeiro1, André R Brunoni2, Felipe Fregni3. 1. Departamento de Psiquiatria, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Sao Paulo, SP, Brazil. 2. Centro de Pesquisa Clínica, Hospital Universitário, Universidade de São Paulo, Sao Paulo, SP, Brazil. 3. Laboratory of Neuromodulation, Harvard Medical School, Harvard University, United States.
Abstract
UNLABELLED: We reviewed trigeminal nerve stimulation (TNS) and transcutaneous vagus nerve stimulation (tVNS). All techniques have shown preliminary promising results, although the results are mixed. METHOD: We performed a systematic review of the Medline and Embase databases, with no constraint to dates, through June 2013. The keywords were [(1) trigeminal nerve stimulation OR (2) cranial nerve OR (3) trigemin* OR (4) transcutaneous VNS OR (5) transcutaneous cranial nerve stimulation] and (6) mental disorders. RESULTS: We included four preclinical and clinical five studies on TNS. All clinical data were based on open-label studies with small samples, which diminished the external validity of the results, thus reflecting the modest impact of TNS in current clinical practice. Of the tVNS clinical trials, three assessed physiological features in healthy volunteers, and one examined patients with epilepsy. CONCLUSION: TNS and tVNS improve treatment of particular neuropsychiatric disorders such as depression.
UNLABELLED: We reviewed trigeminal nerve stimulation (TNS) and transcutaneous vagus nerve stimulation (tVNS). All techniques have shown preliminary promising results, although the results are mixed. METHOD: We performed a systematic review of the Medline and Embase databases, with no constraint to dates, through June 2013. The keywords were [(1) trigeminal nerve stimulation OR (2) cranial nerve OR (3) trigemin* OR (4) transcutaneous VNS OR (5) transcutaneous cranial nerve stimulation] and (6) mental disorders. RESULTS: We included four preclinical and clinical five studies on TNS. All clinical data were based on open-label studies with small samples, which diminished the external validity of the results, thus reflecting the modest impact of TNS in current clinical practice. Of the tVNS clinical trials, three assessed physiological features in healthy volunteers, and one examined patients with epilepsy. CONCLUSION:TNS and tVNS improve treatment of particular neuropsychiatric disorders such as depression.
Authors: Zengjian Wang; Jiliang Fang; Jun Liu; Peijing Rong; Kristen Jorgenson; Joel Park; Courtney Lang; Yang Hong; Bing Zhu; Jian Kong Journal: J Psychiatr Res Date: 2017-12-28 Impact factor: 4.791
Authors: Christopher W Austelle; Georgia H O'Leary; Sean Thompson; Elise Gruber; Alex Kahn; Andrew J Manett; Baron Short; Bashar W Badran Journal: Neuromodulation Date: 2021-09-06
Authors: Christopher W Austelle; Georgia H O'Leary; Sean Thompson; Elise Gruber; Alex Kahn; Andrew J Manett; Baron Short; Bashar W Badran Journal: Neuromodulation Date: 2021-09-06
Authors: Ryan Marshall; Ian Taylor; Christopher Lahr; Thomas L Abell; Ingrid Espinoza; Nitin K Gupta; Christian R Gomez Journal: Clin Med Insights Gastroenterol Date: 2015-12-06